219 related articles for article (PubMed ID: 16481213)
1. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.
Zhou J; Shephard EA
Mutat Res; 2006 Jun; 612(3):165-171. PubMed ID: 16481213
[TBL] [Abstract][Full Text] [Related]
2. Trimethylaminuria (fish odor syndrome): genotype characterization among Portuguese patients.
Ferreira F; Esteves S; Almeida LS; Gaspar A; da Costa CD; Janeiro P; Bandeira A; Martins E; Teles EL; Garcia P; Azevedo L; Vilarinho L
Gene; 2013 Sep; 527(1):366-70. PubMed ID: 23791655
[TBL] [Abstract][Full Text] [Related]
3. Novel variants of the human flavin-containing monooxygenase 3 (FMO3) gene associated with trimethylaminuria.
Motika MS; Zhang J; Zheng X; Riedler K; Cashman JR
Mol Genet Metab; 2009 Jun; 97(2):128-35. PubMed ID: 19321370
[TBL] [Abstract][Full Text] [Related]
4. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation.
Cashman JR; Zhang J
Drug Metab Dispos; 2002 Oct; 30(10):1043-52. PubMed ID: 12228178
[TBL] [Abstract][Full Text] [Related]
5. Human flavin-containing monooxygenase form 3: cDNA expression of the enzymes containing amino acid substitutions observed in individuals with trimethylaminuria.
Cashman JR; Bi YA; Lin J; Youil R; Knight M; Forrest S; Treacy E
Chem Res Toxicol; 1997 Aug; 10(8):837-41. PubMed ID: 9282831
[TBL] [Abstract][Full Text] [Related]
6. Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.
Cashman JR
Pharmacogenomics; 2002 May; 3(3):325-39. PubMed ID: 12052141
[TBL] [Abstract][Full Text] [Related]
7. FMO3 allelic variants in Sicilian and Sardinian populations: trimethylaminuria and absence of fish-like body odor.
D'Angelo R; Esposito T; Calabrò M; Rinaldi C; Robledo R; Varriale B; Sidoti A
Gene; 2013 Feb; 515(2):410-5. PubMed ID: 23266626
[TBL] [Abstract][Full Text] [Related]
8. Compound heterozygosity for missense mutations in the flavin-containing monooxygenase 3 (FM03) gene in patients with fish-odour syndrome.
Dolphin CT; Janmohamed A; Smith RL; Shephard EA; Phillips IR
Pharmacogenetics; 2000 Dec; 10(9):799-807. PubMed ID: 11191884
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of flavin-containing monooxygenase (FMO).
Krueger SK; Williams DE; Yueh MF; Martin SR; Hines RN; Raucy JL; Dolphin CT; Shephard EA; Phillips IR
Drug Metab Rev; 2002 Aug; 34(3):523-32. PubMed ID: 12214664
[TBL] [Abstract][Full Text] [Related]
10. [Fish odour--could be a sign of trimethylaminuria].
Haugaard LK; Lund AM; Patursson P; Christensen E
Ugeskr Laeger; 2010 Nov; 172(47):3268-9. PubMed ID: 21092725
[TBL] [Abstract][Full Text] [Related]
11. Missense mutation in flavin-containing mono-oxygenase 3 gene, FMO3, underlies fish-odour syndrome.
Dolphin CT; Janmohamed A; Smith RL; Shephard EA; Phillips IR
Nat Genet; 1997 Dec; 17(4):491-4. PubMed ID: 9398858
[TBL] [Abstract][Full Text] [Related]
12. Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication.
Treacy EP; Akerman BR; Chow LM; Youil R; Bibeau C; Lin J; Bruce AG; Knight M; Danks DM; Cashman JR; Forrest SM
Hum Mol Genet; 1998 May; 7(5):839-45. PubMed ID: 9536088
[TBL] [Abstract][Full Text] [Related]
13. Two novel mutations of the FMO3 gene in a proband with trimethylaminuria.
Akerman BR; Forrest S; Chow L; Youil R; Knight M; Treacy EP
Hum Mutat; 1999; 13(5):376-9. PubMed ID: 10338091
[TBL] [Abstract][Full Text] [Related]
14. Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria.
Zhang J; Tran Q; Lattard V; Cashman JR
Pharmacogenetics; 2003 Aug; 13(8):495-500. PubMed ID: 12893987
[TBL] [Abstract][Full Text] [Related]
15. Variants in the flavin-containing monooxygenase 3 (FMO3) gene responsible for trimethylaminuria in a Japanese population.
Shimizu M; Kobayashi Y; Hayashi S; Aoki Y; Yamazaki H
Mol Genet Metab; 2012 Nov; 107(3):330-4. PubMed ID: 22819296
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants of flavin-containing monooxygenase 3 (FMO3) derived from Japanese subjects with the trimethylaminuria phenotype and whole-genome sequence data from a large Japanese database.
Shimizu M; Yoda H; Nakakuki K; Saso A; Saito I; Hishinuma E; Saito S; Hiratsuka M; Yamazaki H
Drug Metab Pharmacokinet; 2019 Oct; 34(5):334-339. PubMed ID: 31401033
[TBL] [Abstract][Full Text] [Related]
17. In vivo variability of TMA oxidation is partially mediated by polymorphisms of the FMO3 gene.
Lambert DM; Mamer OA; Akerman BR; Choinière L; Gaudet D; Hamet P; Treacy EP
Mol Genet Metab; 2001 Jul; 73(3):224-9. PubMed ID: 11461189
[TBL] [Abstract][Full Text] [Related]
18. [Individual differences of drug-metabolizing enzymes as determinants for the metabolic fate of chemicals--a study of trimethylamine and flavin-containing monooxygenase 3-].
Shimizu M
Yakugaku Zasshi; 2009 Nov; 129(11):1351-6. PubMed ID: 19881207
[TBL] [Abstract][Full Text] [Related]
19. Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease.
Phillips IR; Shephard EA
Xenobiotica; 2020 Jan; 50(1):19-33. PubMed ID: 31317802
[TBL] [Abstract][Full Text] [Related]
20. Novel variants and haplotypes of human
Shimizu M; Yoda H; Igarashi N; Makino M; Tokuyama E; Yamazaki H
Xenobiotica; 2019 Oct; 49(10):1244-1250. PubMed ID: 30351217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
